Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (238)

2022

  1. A Score to Assess Mortality After Percutaneous Mitral Valve Repair

    Journal of the American College of Cardiology, Vol. 79, Núm. 6, pp. 562-573

  2. Aetiological diagnosis of hyponatraemia in non-critical patients on total parenteral nutrition: A prospective multicentre study

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 160-167

  3. Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy: A Multicenter Observational Study

    Drug and Alcohol Dependence, Vol. 230

  4. Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 669-680

  5. Clinical and economic impact of cardiac magnetic resonance-guided decision-making

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 610-612

  6. Interregional variability in the use of cardiovascular technologies (2011-2019). Correlation with economic indicators, admissions, and in-hospital mortality

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 806-816

  7. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  8. Outcomes of Nonagenarians With Acute Coronary Syndrome

    Journal of the American Medical Directors Association, Vol. 23, Núm. 1, pp. 81-86.e4

  9. Prognostic Impact of Nutritional Status After Transcatheter Edge-to-Edge Mitral Valve Repair: The MIVNUT Registry

    Journal of the American Heart Association, Vol. 11, Núm. 20

  10. Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival

    British Journal of Haematology, Vol. 198, Núm. 2, pp. 278-287

  11. Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD

    Therapeutic Advances in Hematology, Vol. 13